Pharmaceuticals

Elan Corp rejects increased offer from Royalty Pharma

10 Jun 2013

AstraZeneca to acquire respiratory drug company Pearl Therapeutics in $1.15 bn deal

10 Jun 2013

Canada’s Valeant backs out from buying Serbia’s Galenika Pharmaceuticals

08 Jun 2013

Apollo Pharma reviewing sale of Ranbaxy drugs, but no ban yet

08 Jun 2013

Battle for Elan intensifies as Royalty Pharma raises bid to $6.7 bn

08 Jun 2013

Royalty Pharma, which buys royalty streams of patented drugs, sweetened its offer after its earlier bid was accepted by only 7.7 per cent of Elan’s shareholders.

RPG Life Sciences sells surplus land in Navi Mumbai to Maruti Suzuki

07 Jun 2013

Cinven, KKR, Warburg to place second-round bids for PRA

05 Jun 2013

AstraZeneca's withdrawal of drug from regulatory tests hits partner Rigel's shares

05 Jun 2013

Government sees plot to malign India’s pharma industry

03 Jun 2013

‘There is a strong reason to believe that some of the spurious drugs detected in the international markets, alleged to be exported from India, are desperate attempts by countries getting affected by the strength of Indian pharma industry’

Dr Reddy’s, Fuji Corp terminate Japan partnership deal

03 Jun 2013

Sun Pharma in discussion to acquire controlling stake in Meda AB

31 May 2013

Sun Pharmaceutical Industries is in discussions to acquire a controlling stake in Swedish drugmaker Meda AB  for around $5 billion to boost its generics business in developed markets

Drug pricing mechanism to impact near term pharma sector revenues

30 May 2013

GlaxoSmithKline to buy Swiss biotech firm Okairos

29 May 2013

Amgen to form Japanese venture with Astellas Pharma

29 May 2013

The two companies will focus on the co-development and co-commercialisation  of five Amgen pipeline medicines in the Japanese market

Indian doctors’ body asks DCGI to probe Ranbaxy drug quality

29 May 2013

The Indian Medical Association has asked the Drug Controller General of India to investigate the quality of drugs manufactured and sold by Ranbaxy Laboratories in India

Wockhardt reports consolidated Q4 net profit of Rs334.767 crore

28 May 2013

AstraZeneca to acquire Omthera Pharmaceuticals in $443 mn deal

28 May 2013

Valeant to acquire Bausch & Lomb for $8.7 bn

27 May 2013

Valeant Pharmaceuticals International  today said that it will buy out global eye care major Bausch & Lomb Holdings Inc for $8.7 billion in cash from PE firm Warburg Pincus

Canada’s Valeant in talks to buy Bausch & Lomb for $9 bn

25 May 2013

After abandoning its $13 billion cash and stock bid for generic drug giant Actavis, Valeant, one of the most acquisitive pharmaceutical companies, has identified on Bausch and Lomb to strengthen its visual-care products

Ireland’s Elan rejects Royalty Pharma’s sweetened $6.4 bn bid

24 May 2013

Daiichi admits Ranbaxy hid info from US drug regulators

23 May 2013

UK’s specialty pharma firm BTG spends $380 million on two acquisitions

23 May 2013

Pfizer to spin-off rest of animal health unit Zoetis to shareholders

22 May 2013

Drugs found to both prevent and treat Alzheimer’s in mice

22 May 2013

Merck & Co to buy back $5-bn worth stock

22 May 2013

Merck, the second-largest US drugmaker, will repurchase about 99.5 million shares from Goldman Sachs at current market prices